Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape-and structure-based virtual screening techniques

G Costa, R Rocca, A Corona, N Grandi… - European journal of …, 2019 - Elsevier
In this work we report a parallel application of both docking-and shape-based virtual
screening (VS) methods, followed by Molecular Dynamics simulations (MDs), for discovering …

Search for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoring

G Barreiro, CRW Guimarães… - Journal of chemical …, 2007 - ACS Publications
A virtual screening protocol has been applied to seek non-nucleoside inhibitors of HIV-1
reverse transcriptase (NNRTIs) and its K103N mutant. First, a chemical similarity search on …

Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint-and pharmacophore-based virtual screening approach

S Distinto, F Esposito, J Kirchmair, MC Cardia… - European journal of …, 2012 - Elsevier
We report the first application of ligand-based virtual screening (VS) methods for discovering
new compounds able to inhibit both human immunodeficiency virus type 1 (HIV-1) reverse …

In Silico Screening for Non‐nucleoside HIV‐1 Reverse Transcriptase Inhibitors Using Physicochemical Filters and High‐Throughput Docking Followed by In Vitro …

Y Bustanji, IM Al‐Masri, A Qasem… - Chemical biology & …, 2009 - Wiley Online Library
Reverse transcriptase, being the pivot in human immunodeficiency virus replication, is one
of the most attractive targets for the development of new antiretroviral agents. We applied a …

Structure-based virtual screening efforts against HIV-1 reverse transcriptase to introduce the new potent non-nucleoside reverse transcriptase inhibitor

Y Hosseini, A Mollica, S Mirzaie - Journal of Molecular Structure, 2016 - Elsevier
The human immunodeficiency virus (HIV) which is strictly related to the development of
AIDS, is treated by a cocktail of drugs, but due its high propensity gain drug resistance, the …

Discovery of wild-type and Y181C mutant non-nucleoside HIV-1 reverse transcriptase inhibitors using virtual screening with multiple protein structures

SE Nichols, RA Domaoal, VV Thakur… - Journal of chemical …, 2009 - ACS Publications
To discover non-nucleoside inhibitors of HIV-1 reverse transcriptase (NNRTIs) that are
effective against both wild-type (WT) virus and variants that encode the clinically …

Discovery of novel inhibitors of HIV‐1 reverse transcriptase through virtual screening of experimental and theoretical ensembles

A Ivetac, SE Swift, PL Boyer, A Diaz… - Chemical biology & …, 2014 - Wiley Online Library
Non‐nucleoside reverse transcriptase inhibitors (NNRTI s) are potent anti‐HIV
chemotherapeutics. Although there are FDA‐approved NNRTI s, challenges such as the …

In silico screening of HIV-1 non-nucleoside reverse transcriptase and protease inhibitors

A Leitão, AD Andricopulo, CA Montanari - European journal of medicinal …, 2008 - Elsevier
Two targets, reverse transcriptase (RT) and protease from HIV-1, were used during the past
two decades to the discovery of non-nucleoside reverse transcriptase inhibitors (NNRTI) and …

Virtual screening studies on HIV-1 reverse transcriptase inhibitors to design potent leads

S Vadivelan, TN Deeksha, S Arun, PK Machiraju… - European journal of …, 2011 - Elsevier
The purpose of this study is to identify novel and potent inhibitors against HIV-1 reverse
transcriptase (RT). The crystal structure of the most active ligand was converted into a …

New strategy for identifying potential natural HIV-1 non-nucleoside reverse transcriptase inhibitors against drug-resistance: an in silico study

Y Wang, X Wang, Y Xiong, AC Kaushik… - Journal of …, 2020 - Taylor & Francis
Non-nucleosides reverse transcriptase inhibitors (NNRTIs), specifically targeting the HIV-1
reverse transcriptase (RT), play a unique role in anti-AIDS agents due to their high antiviral …